Intel Corporation announced plans to invest more than $7 billion for a semiconductor factory in Chandler, Arizona, the US.
Intel said the new chipset plant will create 3,000 direct and 10,000 indirect jobs in the U.S. The new announcement reflects US President Donald Trump’s demand to create jobs for more Americans in their nation.
The Fab 42 semiconductor factory, which will be completed in 3 to 4 years, is targeted to use the 7 nanometer (nm) manufacturing process. It will produce microprocessors to power data centers and smart and connected devices. U.S. President Donald Trump and Intel CEO Brian Krzanich made the announcement at the White House.
Intel’s semiconductor factory will directly create approximately 3,000 high-tech, high-wage jobs for process engineers, equipment technicians, and facilities-support engineers and technicians who will work at the site. The total jobs created by the investment will be more than 10,000 in Arizona.
“Intel’s business continues to grow and investment in manufacturing capacity and R&D ensures that the pace of Moore’s law continues to march on, fueling technology innovations the world loves and depends on. This factory will help the U.S. maintain its position as the leader in the semiconductor industry,” said Intel CEO Brian Krzanich in an e-mail to employees.
Intel is America’s largest high-technology capital expenditure investor ($5.1 billion in the U.S. 2015) and its third largest investor in global R&D ($12.1 billion in 2015).
Since the majority of Intel’s manufacturing and R&D is in the US, Intel employs more than 50,000 people in the United States, while directly supporting almost half a million other U.S. jobs across a range of industries, including semiconductor tooling, software, logistics, channels, OEMs and other manufacturers that incorporate Intel products into theirs.
The chips made on the 7 nm process will power sophisticated computers, data centers, sensors and other high-tech devices, and enable things like artificial intelligence, advanced cars and transportation services, breakthroughs in medical research and treatment, and more.
